Vivek Subbiah: The evidence for different approaches to colorectal cancer screening is reviewed and a framework for evaluation of screening programs going forward is proposed.

Vivek Subbiah, the Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, recently tweeted:

“Screening for colorectal cancer is widespread and successful, but screening programs across the globe differ in their recommendations. In this review article, the evidence for different approaches to colorectal cancer screening is reviewed and a framework for evaluation of screening programs going forward is proposed.”

For the article click here.
Source: Vivek Subbiah/LinkedIn